Oliver Howes

45.8k total citations · 19 hit papers
435 papers, 27.7k citations indexed

About

Oliver Howes is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Oliver Howes has authored 435 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Psychiatry and Mental health, 154 papers in Cognitive Neuroscience and 132 papers in Cellular and Molecular Neuroscience. Recurrent topics in Oliver Howes's work include Schizophrenia research and treatment (189 papers), Functional Brain Connectivity Studies (127 papers) and Neurotransmitter Receptor Influence on Behavior (73 papers). Oliver Howes is often cited by papers focused on Schizophrenia research and treatment (189 papers), Functional Brain Connectivity Studies (127 papers) and Neurotransmitter Receptor Influence on Behavior (73 papers). Oliver Howes collaborates with scholars based in United Kingdom, United States and Italy. Oliver Howes's co-authors include Robert A. McCutcheon, Shitij Kapur, Robin Murray, Philip McGuire, Tiago Reis Marques, Toby Pillinger, Katherine Beck, Federico Turkheimer, Alice Egerton and Anissa Abi‐Dargham and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Oliver Howes

415 papers receiving 27.3k citations

Hit Papers

The Dopamine Hypothesis of Schizophrenia: Version III--Th... 2009 2026 2014 2020 2009 2019 2012 2019 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
    2009 1.9k citations Oliver Howes et al. Schizophrenia Bulletin profile →
  2. Schizophrenia—An Overview
    2019 846 citations Robert A. McCutcheon, Tiago Reis Marques et al. profile →
  3. The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
    2012 685 citations Oliver Howes, Anissa Abi‐Dargham et al. profile →
  4. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
    2019 614 citations Toby Pillinger, Robert A. McCutcheon et al. profile →
  5. Schizophrenia: an integrated sociodevelopmental-cognitive model
    2013 599 citations Oliver Howes, Robin Murray profile →
  6. Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
    2009 570 citations Oliver Howes, Robin Murray et al. profile →
  7. Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
    2020 563 citations Emanuele F. Osimo, Toby Pillinger et al. profile →
  8. Cognitive Functioning in Prodromal Psychosis
    2012 548 citations Oliver Howes, Philip McGuire et al. profile →
  9. Glutamate and dopamine in schizophrenia: An update for the 21 st century
    2015 521 citations Oliver Howes, Robert A. McCutcheon et al. Journal of Psychopharmacology profile →
  10. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness
    2016 511 citations Sudhakar Selvaraj, Oliver Howes et al. profile →
  11. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
    2019 499 citations Robert A. McCutcheon, Anissa Abi‐Dargham et al. profile →
  12. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
    2016 400 citations Oliver Howes, Robert A. McCutcheon et al. profile →
  13. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
    2020 392 citations Robert A. McCutcheon, Oliver Howes et al. World Psychiatry profile →
  14. Impaired Glucose Homeostasis in First-Episode Schizophrenia
    2017 327 citations Toby Pillinger, Sameer Jauhar et al. profile →
  15. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
    2017 310 citations Abhishekh H. Ashok, Tiago Reis Marques et al. Molecular Psychiatry profile →
  16. The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves
    2021 277 citations Oliver Howes et al. profile →
  17. Treatment resistance in psychiatry: state of the art and new directions
    2021 196 citations Oliver Howes, Toby Pillinger et al. Molecular Psychiatry profile →
  18. Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
    2022 144 citations Oliver Howes, Ekaterina Shatalina profile →
  19. Glucagon-Like Peptide 1 Receptor Agonists and Mental Health
    2025 18 citations Oliver Howes, Robert A. McCutcheon et al. profile →

Peers

Oliver Howes
Comparison fields: 5 of 184
  • Psychiatry and Mental health 11.8k
  • Cognitive Neuroscience 7.5k
  • Cellular and Molecular Neuroscience 6.8k
  • Biological Psychiatry 5.3k
  • Molecular Biology 4.4k
Replace Stefan Borgwardt with:
Stefan Borgwardt Switzerland
Peter Falkai Germany
Ole A. Andreassen Norway
Carol A. Tamminga United States
Shitij Kapur Canada
Donald Goff United States
René S. Kahn Netherlands
Anissa Abi‐Dargham United States
Steven G. Potkin United States
Richard S.E. Keefe United States
Stefan Borgwardt Switzerland View profile →
Citations per field, relative to Oliver Howes
Oliver Howes · 1×
Citations per year, relative to Oliver Howes
Oliver Howes · 1×

Countries citing papers authored by Oliver Howes

Since Specialization
Citations

This map shows the geographic impact of Oliver Howes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Howes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Howes more than expected).

Fields of papers citing papers by Oliver Howes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Howes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Howes. The network helps show where Oliver Howes may publish in the future.

Co-authorship network of co-authors of Oliver Howes

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Howes. A scholar is included among the top collaborators of Oliver Howes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Howes. Oliver Howes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
The hypothesis of biologically based subtypes of schizophrenia: a 10‐year update
2025 ·World Psychiatry ·Oliver Howes, (unknown), Sameer Jauhar, Robert A. McCutcheon
2
2
Mitochondria and Cognition: An [18F]BCPP-EF Positron Emission Tomography Study of Mitochondrial Complex I Levels and Brain Activation During Task Switching
2025 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·Ekaterina Shatalina, Thomas Whitehurst, Ellis Chika Onwordi, Alex Whittington, Ayla Mansur, Atheeshaan Arumuham, Tiago Reis Marques, Roger N. Gunn, Sridhar Natesan, Matthew M. Nour, Eugenii A. Rabiner, Matthew B. Wall, Oliver Howes
1
3
The role of low subcortical iron, white matter myelin, and oligodendrocytes in schizophrenia: a quantitative susceptibility mapping and diffusion tensor imaging study
2025 ·Molecular Psychiatry ·Luke Vano, Robert A. McCutcheon, Jan Sedlacik, Grazia Rutigliano, Stephen J. Kaar, (unknown), (unknown), (unknown), Ben Statton, Amir Fazlollahi, Ian Everall, Oliver Howes
0
4
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study
2025 ·American Journal of Psychiatry ·Luke Vano, Robert A. McCutcheon, Jan Sedlacik, Stephen J. Kaar, Grazia Rutigliano, (unknown), (unknown), Leigh Townsend, (unknown), Ben Statton, Amir Fazlollahi, Mattia Veronese, Seth C. Hopkins, Kenneth S. Koblan, Ian Everall, Oliver Howes
1
5
Physically informed deep neural networks for metabolite-corrected plasma input function estimation in dynamic PET imaging
2024 ·Computer Methods and Programs in Biomedicine ·(unknown), Marianna Inglese, (unknown), (unknown), (unknown), Federico Turkheimer, Maria Antonietta Nettis, Valeria Mondelli, Oliver Howes, Marco L. Loggia, Mattia Veronese, Nicola Toschi
3
6
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
2024 ·SHILAP Revista de lepidopterología ·(unknown), Fernando Zelaya, Kyra-Verena Sendt, Grant McQueen, Amy Gillespie, John Lally, Oliver Howes, Gareth J. Barker, Philip McGuire, James H. MacCabe, Alice Egerton
0
7
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
2023 ·Translational Psychiatry ·Sameer Jauhar, Robert A. McCutcheon, Mattia Veronese, Faith Borgan, Matthew M. Nour, Maria Rogdaki, Fiona Pepper, James Stone, Alice Egerton, George Vamvakas, Federico Turkheimer, Philip McGuire, Oliver Howes
5
8
Emerging Treatments in Schizophrenia
2022 ·The Journal of Clinical Psychiatry ·Christoph U. Correll, Anissa Abi‐Dargham, Oliver Howes
18
9
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
2022 ·Neuropsychopharmacology ·Alice Egerton, (unknown), (unknown), J.F.W. Deakin, Richard Drake, Oliver Howes, Laura Kassoumeri, Sobia Khan, (unknown), Jane Lees, Shôn Lewis, (unknown), Edward Millgate, Ebenezer Oloyede, (unknown), (unknown), Aviv Segev, Kyra-Verena Sendt, James H. MacCabe
14
10
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
2021 ·Neuropsychopharmacology ·Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs G. Bossong, Nicolás Crossley, Jesús Pérez, James Stone, Mattia Veronese, Fernando Zelaya, Anthony A. Grace, Oliver Howes, Paul Allen, Philip McGuire
22
11
The role of mitochondria in the pathophysiology of schizophrenia: A critical review of the evidence focusing on mitochondrial complex one
2021 ·Neuroscience & Biobehavioral Reviews ·Thomas Whitehurst, Oliver Howes
26
12
Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study
2021 ·Journal of Psychopharmacology ·Abhishekh H. Ashok, Jim Myers, Gary Frost, Samuel Turton, Roger N. Gunn, Jan Passchier, Alessandro Colasanti, Tiago Reis Marques, David Nutt, Anne Lingford‐Hughes, Oliver Howes, Eugenii A. Rabiner
2
13
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
2021 ·Translational Psychiatry ·Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, Ben Statton, (unknown), Marina Quinlan, Declan P. O’Regan, Maria Rogdaki, Tiago Reis Marques, Eugenii A. Rabiner, Roger N. Gunn, Anthony C. Vernon, Sridhar Natesan, Oliver Howes
36
14
Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case–control study
2021 ·Translational Psychiatry ·Emanuele F. Osimo, Mark Sweeney, Antonio de Marvao, (unknown), Ben Statton, Benjamin I. Perry, Toby Pillinger, Thomas Whitehurst, Stuart A. Cook, Declan P. O’Regan, E. Louise Thomas, Oliver Howes
15
15
Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis
2020 ·Schizophrenia Bulletin ·Santosh Lamichhane, Alex M. Dickens, Partho Sen, Heikki Laurikainen, Faith Borgan, Jaana Suvisaari, Tuulia Hyötyläinen, Oliver Howes, Jarmo Hietala, Matej Orešič
8
16
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
2019 ·Neuropsychopharmacology ·Oliver Howes, Ilaria Bonoldi, Robert A. McCutcheon, Matilda Azis, Mathilde Antoniades, Matthijs G. Bossong, Gemma Modinos, Jesús Pérez, James Stone, (unknown), Mattia Veronese, Anthony A. Grace, Paul Allen, Philip McGuire
23
17
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis
2018 ·Neuropsychopharmacology ·Gemma Modinos, Fatma Şimşek, Matilda Azis, Matthijs G. Bossong, Ilaria Bonoldi, Carly Samson, (unknown), Jesús Pérez, Matthew R. Broome, Fernando Zelaya, David J. Lythgoe, Oliver Howes, James Stone, Anthony A. Grace, Paul Allen, Philip McGuire
39
18
Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study
2017 ·Neuropsychopharmacology ·Sudhakar Selvaraj, Christopher Walker, Danilo Arnone, Bo Cao, Paul Faulkner, Philip J. Cowen, Jonathan P. Roiser, Oliver Howes
29
19
Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [11C]MePPEP
2014 ·NeuroImage ·Daniela A. Riaño Barros, Colm J. McGinnity, Lula Rosso, Rolf A. Heckemann, Oliver Howes, David J. Brooks, John S. Duncan, Federico Turkheimer, Matthias J. Koepp, Alexander Hammers
16
20
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
2011 ·American Journal of Psychiatry ·Oliver Howes, Subrata K. Bose, Federico Turkheimer, Isabel Valli, Alice Egerton, Lucia Valmaggia, Robin Murray, Philip McGuire
274

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Borgwardt Breakdown of academic impact, for papers by Peter Falkai Breakdown of academic impact, for papers by Ole A. Andreassen Breakdown of academic impact, for papers by Carol A. Tamminga Breakdown of academic impact, for papers by Shitij Kapur Breakdown of academic impact, for papers by Donald Goff Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by Anissa Abi‐Dargham Breakdown of academic impact, for papers by Steven G. Potkin Breakdown of academic impact, for papers by Richard S.E. Keefe
Rankless by CCL
2026